Fundraising Fox
/Companies
Sign in

Speratum

1 known investors

Find your way into Speratum

Sign up to see every warm intro you have to Speratum

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Speratum team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Speratum Biopharma develops RNA interference (RNAi) therapeutics for cancer and other hard-to-treat genetic diseases, using its proprietary NoPass RNAi design platform and Nano-In nanoparticle delivery system. Its lead candidate, NM-198, is based on the tumor-suppressor microRNA miR-198 and targets multiple oncogenic pathways in solid tumors.

BiotechDeep TechHealthtech

Founders & leadership

CMChristian Marín Müller
Christian Marín MüllerFounderChristian Marín Müller holds a Ph.D. in Molecular Virology and Microbiology from Baylor College of Medicine and an MS in Entrepreneurial Biotechnology from Case Western Reserve University. He worked as a Post-Doctoral Associate in the Department of Surgery at Baylor College of Medicine, developing RNA interference therapeutics for cancer before founding Speratum in 2014, a pre-clinical stage biopharmaceutical company focused on RNAi-based cancer treatments using novel nanoparticle delivery systems.

Investors · 1

Frequently asked questions

What does Speratum do?
Speratum Biopharma develops RNA interference (RNAi) therapeutics for cancer and other hard-to-treat genetic diseases, using its proprietary NoPass RNAi design platform and Nano-In nanoparticle delivery system. Its lead candidate, NM-198, is based on the tumor-suppressor microRNA miR-198 and targets multiple oncogenic pathways in solid tumors.
Who founded Speratum?
Speratum was founded by Christian Marín Müller.
Who are Speratum's investors?
Speratum's investors include Carao Ventures.